AD	Alzheimer’s disease
AGE	advanced glycation end-product
ALS	amyotrophic lateral sclerosis
ApoE	apolipoprotein E
APP	amyloid precursor protein
ATP	adenosine triphosphate
Aβ	amyloid β
BACE	beta-site amyloid precursor protein cleaving enzyme
BBB	blood-brain barrier
CCH	chronic cerebral hypoperfusion
CK	creatine kinase
CMA	carboxymethyl arginine
CML	carboxymethyl lysine
CSF	cerebrospinal fluid
CTX	Cortex
GPx	glutathione peroxidase
GS	glutamine synthetase
GSH	Glutathione
GSSG	glutathione disulfide
GST	glutathione-S-transferase
HNE	Hydroxynonenal
H2O2	hydrogen peroxide
LRP-1	low-density lipoprotein receptor-related protein 1
MCI	mild cognitive impairment
MCP-1	monocyte chemotactic protein-1
MDA	Malondialdehyde
MitoQ	mitoquinone mesylate
MMP9	matrix metalloproteinase 9
MMSE	mini-mental state examination
MRI	magnetic resonance imaging
MRP1	multidrug resistance protein 1
NADPH	nicotinamide adenine dinucleotide phosphate
NFT	neurofibrillary tangles
NLRP3	NACHT, LRP and PYD domains-containing protein 3
NMDA	N-methyl-D-aspartate
O2•-	superoxide anion
•OH	hydroxyl radical
PET	positron emission tomography
PIB	Pittsburg compound B
pTau	phosphorylated tau
RAGE	receptor for advanced glycation end-product
RNS	reactive nitrogen species
ROS	reactive oxygen species
SkQ1	plastoquinonyl-decyltriphenylphosphonium
SLCP	solid lipid curcumin particles
SOD	superoxide dismutase
TH	Thalamus
TNF-α	tumor necrosis factor-α
TRF	tocotrienol-rich fraction
TwX	Twendee X
WMH	white matter hyperintensity
8-OHdG	8-hydroxy-2′-deoxyguanosine